Gossamer Bio

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$9,379
$9,480
$95,842
$0
Gross Profit
9,379
9,480
94,850
-986
EBITDA
-31,626
-28,103
53,079
-37,813
EBIT
-32,701
-29,201
52,087
-38,799
Net Income
-33,029
-30,803
49,232
-41,928
Net Change In Cash
9,379
9,480
95,842
0
Free Cash Flow
-35,481
-32,033
116,348
-52,302
Cash
46,074
28,464
86,877
38,863
Basic Shares
226,228
226,346
238,543
225,735

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$114,701
$0
$0
$0
Gross Profit
114,701
-4,385
-4,429
-5,167
EBITDA
-39,967
-172,152
-211,069
-209,322
EBIT
-44,118
-173,759
-215,498
-214,489
Net Income
-56,528
-179,817
-240,228
-249,076
Net Change In Cash
114,701
0
0
0
Cost of Revenue
-70,977
-302,988
Free Cash Flow
-3,468
-159,158
-187,507
-190,511
Cash
46,074
32,109
111,973
183,403
Basic Shares
226,228
152,621
84,574
74,843

Earnings Calls

Quarter EPS
2024-12-31
-$0.15
2024-09-30
-$0.14
2024-06-30
$0.22
2024-03-31
-$0.19